ANDA 209177, held by Strides Pharma. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 209177 (Promethazine Hydrochloride), held by Strides Pharma, was first approved by FDA on Jun 30, 2017, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 30, 2017 | Original application | Approved | None posted |
| Promethazine Hydrochloride12.5MG · tablet;oral | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride25MG · tablet;oral | Promethazine Hydrochloride | Discontinued |
| Promethazine Hydrochloride50MG · tablet;oral | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters